Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Ciprofloxacin
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Society and culture== ===Economics=== It is available as a generic medication and not very expensive.<ref name=AHFS2015/><ref name=Ric2014/> ===Generic equivalents=== In October 2001, the Prescription Access Litigation (PAL) project filed suit to dissolve an agreement between Bayer and three of its competitors which produced [[Generic drugs|generic versions of drugs]] ([[Barr Pharmaceuticals|Barr Laboratories]], [[Actavis|Rugby Laboratories]], and [[Marion Merrell Dow|Hoechst-Marion-Roussel]]) that PAL claimed was blocking access to adequate supplies and cheaper, generic versions of ciprofloxacin. The plaintiffs charged that Bayer Corporation, a unit of Bayer AG, had unlawfully paid the three competing companies a total of $200 million to prevent cheaper, generic versions of ciprofloxacin from being brought to the market, as well as manipulating its price and supply. Numerous other consumer advocacy groups joined the lawsuit. On 15 October 2008, five years after Bayer's patent had expired, the United States District Court for the Eastern District of New York granted Bayer's and the other defendants' motion for summary judgment, holding that any anticompetitive effects caused by the settlement agreements between Bayer and its codefendants were within the exclusionary zone of the patent and thus could not be redressed by federal antitrust law,<ref>{{cite web |author=United States Court of Appeals for the Federal Circuit |title=United States Court of Appeals for the Federal Circuit |url=http://www.cafc.uscourts.gov/opinions/08-1097.pdf |location=USA |year=2008 |access-date=4 September 2009 |url-status=dead |archive-url=https://web.archive.org/web/20090827080527/http://www.cafc.uscourts.gov/opinions/08-1097.pdf |archive-date=27 August 2009 }}</ref> in effect upholding Bayer's agreement with its competitors. ===Available forms=== Ciprofloxacin for systemic administration is available as immediate-release tablets, as extended-release tablets, as an oral suspension, and as a solution for intravenous infusion. It is available for local administration as eye drops and ear drops. It is available in combination with [[Ciprofloxacin/dexamethasone|dexamethasone]], with [[Ciprofloxacin/celecoxib|celecoxib]], with [[Ciprofloxacin/hydrocortisone|hydrocortisone]], and with [[Ciprofloxacin/fluocinolone acetonide|fluocinolone acetonide]].<ref>{{cite web | title=Otovel (- ciprofloxacin and fluocinolone acetonide solution | website=DailyMed | date=12 September 2019 | url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a7e4806-3138-4b7a-b798-a99e163ee846 | access-date=9 February 2024}}</ref> ===Litigation=== A class action was filed against Bayer AG on behalf of employees of the Brentwood Post Office in Washington, D.C., and workers at the U.S. Capitol, along with employees of American Media, Inc. in Florida and postal workers in general who alleged they developed serious adverse effects from taking ciprofloxacin in the aftermath of the [[2001 anthrax attacks|anthrax attacks in 2001]]. The action alleged Bayer failed to warn class members of the potential side effects of the drug, thereby violating the Pennsylvania Unfair Trade Practices and Consumer Protection Laws. The class action was defeated and the litigation abandoned by the plaintiffs.<ref>{{cite web |title=Legal Brief of Postal Employees Cases (EEOC, MSPB, District Courts) |url=http://www.lunewsviews.com/legal_briefs_archives.htm#cipro |archive-url=https://web.archive.org/web/20071021073109/http://www.lunewsviews.com/legal_briefs_archives.htm#cipro |archive-date=21 October 2007 |publisher=Postal Reporter |location=USA |access-date=9 September 2009}}</ref> A similar action was filed in 2003 in New Jersey by four New Jersey postal workers but was withdrawn for lack of grounds, as workers had been informed of the risks of ciprofloxacin when they were given the option of taking the drug.<ref>Los Angeles Times, from wire service reports. 19 October 2003 [https://www.latimes.com/archives/la-xpm-2003-oct-19-na-briefs19.2-story.html Postal Workers Sue Over Anthrax Scare Antibiotic] </ref><ref>Bill Lewis, President of Trenton Metro Area Local, American Postal Workers Union, AFL-CIO. 7 December 2003 [http://trentonmetroarealocal.com/president_page.html Trenton Metro Area Local: Welcome to Bill's Corner] {{webarchive |url=https://web.archive.org/web/20141023131440/http://trentonmetroarealocal.com/president_page.html |date=23 October 2014 }} Page accessed 23 October 2014</ref>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Ciprofloxacin
(section)
Add topic